Patterns of Medication Initiation in Newly Diagnosed Diabetes Mellitus: Quality and Cost Implications

Patterns of Medication Initiation in Newly Diagnosed Diabetes Mellitus: Quality and Cost Implications Nihar R. Desai, MD, MPH, William H. Shrank, MD, MSHS, Michael A. Fischer, MD, MS, Jerry Avorn, MD, Joshua N. Liberman, PhD, Sebastian Schneeweiss, MD, ScD, Juliana Pakes, MEd, Troyen A. Brennan, MD, JD, MPH, Niteesh K. Choudhry, MD, PhD Divisions of Pharmacoepidemiology and Pharmacoeconomics and Cardiovascular Medicine, Department of Medicine, Brigham and omen’s Hospital and Harvard Medical School, Boston, Mass; Center for American Political Studies, Harvard University, Boston, ass; and CVS Caremark, Inc, Woonsocket, RI.